SCHEMBL3149807

SCHEMBL3149807

CC(C)CCCCCCCCCCCCCCC[Ti](CCCCCCCCCCCCCCCC(C)C)(C(C)C)C(C)C

nearest known ligand 0.43

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2038809 0.79 LMNA (0.43) LMNA
SCHEMBL1602400 0.78 LMNA (0.48) LMNA
SCHEMBL9821535 0.78 LMNA (0.48) LMNA
SCHEMBL11723029 0.76 LMNA (0.67) LMNA
SCHEMBL20530387 0.76 LMNA (0.67) LMNA
SCHEMBL7580335 0.76 LMNA (0.67) LMNA
SCHEMBL11207754 0.76 LMNA (0.67) LMNA
SCHEMBL21925059 0.76 LMNA (0.67) LMNA
SCHEMBL105972 0.76 LMNA (0.67) LMNA
SCHEMBL104886 0.76 LMNA (0.67) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1865914-B1 IMPROVED OXIDATIVE HAIR DYES BOOTS CO PLC (GB) 2012-08-15 EP claimed
US-7686849-B2 Oxidative hair dyes and related topical compositions THE BOOTS COMPANY PLC. (GB) 2010-03-30 US claimed
US-20080233068-A1 Oxidative Hair Dyes and Related Topical Compositions THE BOOTS COMPANY PLC (GB) 2008-09-25 US claimed
EP-1865914-A1 IMPROVED OXIDATIVE HAIR DYES AND RELATED TOPICAL COMPOSITIONS The Boots Company PLC (GB) 2007-12-19 EP claimed
WO-2006106366-A1 IMPROVED OXIDATIVE HAIR DYES AND RELATED TOPICAL COMPOSITIONS THE BOOTS COMPANY PLC (GB) 2006-10-12 WO claimed
EP-2468524-B2 Improvements relating to laser marking SILTECH LTD (GB) 2018-10-17 EP disclosed
US-9498999-B2 Laser marking SILTECH LIMITED (GB) 2016-11-22 US disclosed
EP-2468524-B1 Improvements relating to laser marking SILTECH LTD (GB) 2014-11-12 EP disclosed
EP-2465691-B1 Improvements relating to laser marking SILTECH LTD (GB) 2014-03-26 EP disclosed
EP-2121821-B1 IMPROVEMENTS RELATING TO LASER MARKING SILTECH LTD (GB) 2013-11-13 EP disclosed
EP-1865914-B1 IMPROVED OXIDATIVE HAIR DYES BOOTS CO PLC (GB) 2012-08-15 EP disclosed
EP-2468524-A1 Improvements relating to laser marking Siltech Limited (GB) 2012-06-27 EP disclosed
EP-2465691-A1 Improvements relating to laser marking Siltech Limited (GB) 2012-06-20 EP disclosed
US-7686849-B2 Oxidative hair dyes and related topical compositions THE BOOTS COMPANY PLC. (GB) 2010-03-30 US disclosed
US-20100018957-A1 LASER MARKING SILTECH LIMITED (GB) 2010-01-28 US disclosed
EP-2121821-A2 IMPROVEMENTS RELATING TO LASER MARKING Siltech Limited (GB) 2009-11-25 EP disclosed
US-20080233068-A1 Oxidative Hair Dyes and Related Topical Compositions THE BOOTS COMPANY PLC (GB) 2008-09-25 US disclosed
WO-2008075101-A2 IMPROVEMENTS RELATING TO LASER MARKING SILTECH LIMITED (GB) 2008-06-26 WO disclosed
EP-1865914-A1 IMPROVED OXIDATIVE HAIR DYES AND RELATED TOPICAL COMPOSITIONS The Boots Company PLC (GB) 2007-12-19 EP disclosed
WO-2006106366-A1 IMPROVED OXIDATIVE HAIR DYES AND RELATED TOPICAL COMPOSITIONS THE BOOTS COMPANY PLC (GB) 2006-10-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080233068-A1 Oxidative Hair Dyes and Related Topical Compositions TYR, LPO, TST LMNA 4653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.